Related Experiment Video
Updated: Aug 11, 2026
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal conjugate vaccine
1Causeway Hospital, Coleraine, County Londonderry, Northern Ireland. michael.ledwith@chsst.n-i.nhs.uk
Insights
New conjugate pneumococcal vaccines offer safe and effective protection for infants, addressing antimicrobial resistance. These vaccines provide a stronger immune response than older types, crucial for young children at high risk.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Microbiology
Background:
- Pneumococcal infections are a major cause of bacterial illness in children.
- Increasing antimicrobial resistance in Streptococcus pneumoniae necessitates novel prevention strategies.
- Existing polysaccharide vaccines are ineffective in infants under two years old.
Purpose of the Study:
- To evaluate the effectiveness and safety of protein-conjugated pneumococcal vaccines.
- To assess the potential of conjugate vaccines in preventing otitis media and reducing nasopharyngeal carriage.
- To highlight the benefits of conjugate vaccines for high-risk infant populations.
Main Methods:
- Review of published clinical trials on protein-conjugated pneumococcal vaccines.
- Analysis of immunogenicity data, focusing on infant responses.
- Assessment of safety profiles and efficacy against pneumococcal disease and related conditions.
Main Results:
- Protein-conjugated pneumococcal vaccines demonstrate effectiveness and safety in clinical trials.
- These vaccines induce a robust and rapid immune response, superior to older formulations.
- Conjugate vaccines show promise in preventing otitis media and decreasing nasopharyngeal carriage of pneumococci.
Conclusions:
- Protein-conjugated pneumococcal vaccines represent a significant advancement in pediatric infectious disease prevention.
- The strategy, supported by successful Haemophilus influenzae type b conjugate vaccines, is effective for infants.
- Widespread adoption of these conjugate vaccines is deemed safe, cost-effective, and crucial for public health.
Abstract:
Pneumococcal infections account for a significant proportion of bacterial infections in infants and children. The growing threat from pneumococci resistant to penicillin and other antimicrobials has led to increased pressure for the development of an effective vaccine. The only vaccine available until recently, a purified polysaccharide vaccine, is limited in that it fails to induce adequate and long-lasting immunity in infants under 2 years of age, the age group most at risk from this disease. Polysaccharide antigens conjugated to certain proteins induce effective immunity with a rapid response to subsequent infection or antigen challenge. The success of the protein-conjugated haemophilus influenzae vaccine supports the strategy of protein-conjugated polysaccharide vaccines. Currently, published trials of conjugated pneumococcal vaccines have shown the effectiveness and safety of these vaccines. Conjugate vaccines also provide protection against otitis media and may eliminate nasopharyngeal carriage of this organism. Widespread use of this vaccine is both cost effective and safe.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:27Streptococcal Pharyngitis
01:29Pneumonia I: Introduction